about
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic reviewRates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiologyEvaluation of a vaccination strategy by serosurveillance data: The case of varicella.Reliability of medical students' vaccination histories for immunisable diseasesVaricella vaccination in Europe - taking the practical approach.Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.Varicella susceptibility and transmission dynamics in Slovenia.Successes and challenges in varicella vaccineVaricella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.Impact of universal vaccination against varicella in Italy.Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trialVaricella-zoster virus susceptibility and primary healthcare consultations in Norway.Single-dose varicella vaccine effectiveness in school settings in China.Reactogenicity to a live attenuated varicella vaccine in Canadian childrenParental Attitudes and Factors Associated With Varicella Vaccination in Preschool and Schoolchildren in Hong Kong: A Cross-Sectional StudyA varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.Herpesvirus infections of the central nervous system in immunocompromised patientsChickenpox, chickenpox vaccination, and shingles.Seroepidemiology of varicella-zoster virus in Korea.Varicella vaccine uptake in Shandong Province, China.Varicella zoster virus-associated morbidity and mortality in Africa: a systematic review protocolNational Immunization Program in Iran: whys and why nots.Epidemiological investigation of a case of chickenpox in a medical college in Kancheepuram, India.Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults.Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial.Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptanceComplete DNA sequences of two oka strain varicella-zoster virus genomes.Varicella infection in the Middle East: Prevalence, complications, and vaccination.
P2860
Q28067076-0C083020-D196-47EF-ACC4-5378A8F4298BQ28650972-B26DC00C-6AF4-44E7-87FA-14D8B0F09323Q30908568-DDA21CD2-D529-4265-A520-35A380D88CC1Q33328310-8A85544F-38C5-4C75-B641-18DBDA505FF5Q33454919-220409B5-0C7C-40FB-A2E4-42790368CCC8Q33500864-7098D12D-466E-47DA-8801-71F5AAC5408DQ33614198-86AE2326-04FB-43FF-8B17-8C3FD88C9909Q34416710-819D13A6-59CC-463E-A04D-EAF229B7651DQ34788015-217147B1-BDB9-4D7F-B957-758D876157BFQ35191241-DC60979F-00AA-4647-813B-B2620FFC7BE9Q35667367-33A6E272-FC68-4BE7-8B3F-8E849AFD9383Q35887043-87E6C675-8CA1-417C-A7CA-955816CA3D33Q35887496-B6BA7C10-1D6D-40B2-BC0C-E55328F85970Q35893127-67EC998D-37E4-4009-94D9-C526BD98CC9CQ36041839-31D14E56-817A-40F9-9084-A5D2AF868374Q36161043-76D7F1C6-DDD3-4781-9E7D-1A7A34A6C382Q36170149-D8FB41C1-6091-4961-A31E-2A59CFEEC869Q36194971-5DBF15D2-6FB1-46D6-997C-0ED42354D9A8Q36205742-1DDB723F-4B5B-4F63-88AA-1BDC2C0ED991Q36220448-62CFA82F-8B58-4671-81C3-6954169317B6Q36470500-E11DF207-2348-4B5C-ADEB-9105B6E09CD2Q36589458-63B52CE5-B8F2-4F49-AFA1-0FCB8AF8EE4DQ36631259-38C0D099-3890-41CF-B377-BF2735677B45Q36819173-5203E220-CEF6-4CC6-8E5F-C61D01F4196EQ36887903-158ED140-7311-4FA9-9418-11EB8B31949CQ37441577-E09D7D0C-49CA-450D-A8EB-6F36867E4619Q37472498-67B27BF6-4F1C-4000-9375-DBEFE1CCB394Q37514787-2BB4355F-0625-4636-9AD4-6F9C6549E231Q41712130-B110ABB5-40A8-4FD8-AA36-A2219B8BCC41Q43251025-B97166AE-C9E0-410F-8C43-DFF53A3CA54AQ54999063-1DDD49B4-4F95-457C-A3BC-1C7ADDB6BF86
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Varicella vaccines. WHO position paper
@ast
Varicella vaccines. WHO position paper
@en
Varicella vaccines. WHO position paper
@nl
type
label
Varicella vaccines. WHO position paper
@ast
Varicella vaccines. WHO position paper
@en
Varicella vaccines. WHO position paper
@nl
prefLabel
Varicella vaccines. WHO position paper
@ast
Varicella vaccines. WHO position paper
@en
Varicella vaccines. WHO position paper
@nl
P3181
P1476
Varicella vaccines. WHO position paper
@en
P3181
P407
P577
1998-08-07T00:00:00Z